IMBRUVICA (IBRUCTINIB) with a Focus on Patients with Mantle Cell Lymphoma ~ LIVE 11/17/21Social Media CoordinatorNov 8, 20211 min read Click image to RSVP or email Joanne. See attached flyer for additional details.Invite_PCY-03167_11.17.21.pdfDownload PDF • 2.93MB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
コメント